An Open-Label Trail with TMC125 in HIV-1 Infected Subjects, who were Randomized to a TMC125 Treatment Arm in a Sponsor-Selected TMC125 Trail and were Treated for at least 48 weeks

Grants and Contracts Details

StatusFinished
Effective start/end date9/8/058/31/12

Funding

  • PPD Development Inc: $55,307.00